Iron overload diseases: An update;Patologie da sovraccarico di ferro: Recenti acquisizioni

Annali Italiani di Medicina Interna

Volumn 19, Issue 3, 2004, Pages 145-154

  Licata, Anna ^a   Brucato, Virna ^a   Di Marco, Vito ^a   Barbaria, Franco ^a   Craxì, Antonio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Hereditary hemochromatosis; HFE gene mutations; Iron overload

Indexed keywords

HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN;

ALGORITHM; GENETICS; HEMOCHROMATOSIS; HUMAN; IRON OVERLOAD; MUTATION; REVIEW;

ALGORITHMS; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON OVERLOAD; MEMBRANE PROTEINS; MUTATION;

EID: 21644481211     PISSN: 03939340     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Parkilla S, Niemela O, Britton RS, et al. Molecular aspects of iron absorption and HFE expression. Gastroenterology 2001; 121: 1489-96.
2. Zoller H, Pietrangelo A, Vogel W, et al. Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet 1999; 353: 2120-2.
3. McKie AT, Marciani P, Rolfs A, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000; 5: 299-309.
4. Vulpe CD, Kuo YM, Murphy TL, et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 1999; 21: 195-9.
5. Bacon BR, Powell LW, Adams PC, et al. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 1999; 116: 193-207.
6. Bridle K, Frazer D, Wilkins S, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homeostasis. Lancet 2003; 361: 669-73.
7. Montosi G, Donovan A, Totaro A, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001; 108: 619-23.
8. Pietrangelo A. Haemochromatosis. Gut 2003; 52 (Suppl 2): 23-30.
9. Camaschella C, Roetto A, Cali A, et al. The gene TFR2 is mutated in a new type of hemochromatosis mapping to 7q22. Nat Genet 2000; 25: 14-5.
10. Roetto A, Daraio F, Alberti F, et al. Hemochromatosis due to mutations in transferrin receptor 2. Blood Cells Mol Dis 2002; 29: 465-70.
11. De Gobbi M, Caruso R, Daraio F, et al. Diagnosis of juvenile hemochromatosis in an 11-year-old child combining genetic analysis and non-invasive liver iron quantitation. Eur J Pediatr 2003; 162: 96-9.
12. Olynk JK, Cullen DJ, Aquilia S, et al. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341: 718-24.
13. Piperno A, Sampietro M, Pietrangelo A, et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998; 114: 996-1002.
14. Rochette J, Pointon JJ, Fisher CA, et al. Multicentric origin of hemochromatosis gene (HFE) mutations. Am J Hum Genet 1999; 64: 1056-62.
15. Feder JN, Gnirke A, Thomas W, et al. Milestones in liver disease: the discovery of the new hemochromatosis gene. J Hepatol 2003; 38: 704-9.
16. Maccari S, Plancher AC. Significance of "minor" genetic mutations in hereditary hemochromatosis: 2 case reports. Ann Ital Med Int 2000; 15: 221-5.
17. Holmstrom P, Marmur J, Eggertsen G, Gafvels M, Stal P. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Gut 2002; 51: 723-30.
18. Iancu TC, Deugnier Y, Hallidey JV, et al. Ultrastructural sequences during liver iron overload in genetic hemochromatosis. J Hepatol 1997; 27: 628-38.
19. Houglum K, Ramm GA, Crawford DH, et al. Excess iron induces hepatic oxidative stress and transforming growth factor beta-1 in genetic hemochromatosis. Hepatology 1997; 26: 605-10.
20. Ramm GA, Crawford DH, Powell LW, et al. Hepatic stellate cell activation in genetic hemochromatosis. J Hepatol 1997; 26: 584-92.
21. Bacon BR, Olynk JK, Brunt EM, et al. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999; 130: 953-62.
22. Tavill A. Diagnosis and management of hemochromatosis. Hepatology 2001; 33: 1323-5.
23. Niederau C, Fischer R, Purschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-19.
24. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 1997; 25: 162-6.
25. Cao A, Gabutti V, Galanello R, et al. Management protocol of the treatment of thalassemia patients. Nicosia, Cyprus: Thalassemia International Federation, 1997.
26. Farrell FJ, Nguyen KM. Outcome of liver transplantation in patients with hemochromatosis. Hepatology 1994; 20: 404-10.
27. Kowdley KV, Hassanein T, Kaur S, et al. Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. Liver Transplant Surg 1995; 1: 237-41.
28. Tsukamoto H, Horne W, Kamimura S, et al. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 1995; 96: 620-30.
29. Duane P, Raja KB, Simpson RJ, Peters TJ. Intestinal iron absorption in chronic alcoholics. Alcohol Alcohol 1992; 27: 539-44.
30. Gordon HM, Wallace DF, Walker AP, et al. The role of HFE mutation in determining predisposition to alcohol-related cirrhosis in a Celtic population [abstract]. Hepatology 1998; 28: 199A.
31. Campos FJ, Gonzalez QA, Fernandez de Troconiz LL, et al. Mutation in the HFE gene (C282Y, H63D, S65C) in alcoholic patients with finding of iron overload. Rev Clin Esp 2000; 202: 534-9.
32. Diwakaran HH, Befeler AS, Britton RS, et al. Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection. Hepatology 2002; 36: 687-91.
33. Piperno A, Sampietro M, D'Alba R, et al. Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C. Liver 1996; 16: 248-54.
34. Pietrangelo A. Hemochromatosis gene modifies course of hepatitis C viral infection. Gastroenterology 2003; 124: 1509-23.
35. Bonkonwsky HL, Banner BF, Rothman AL, et al. Iron and chronic viral hepatitis. Hepatology 1997; 25: 759-68.
36. Erhardt A, Maschner-Olberg A, Mellenthin C, et al. HFE mutations and chronic hepatitis C: H63D and C282Y heterozigosity are independent risk factors for liver fibrosis and cirrhosis. J Hepatol 2003; 38: 335-42.
37. Melis MA, Cau M, Deidda F, et al. H63D mutation in the HFE gene increases iron overload in beta-thalassemia carriers. Haematologica 2002; 87: 242-5.
38. Bacon B, Farahvash M, Janney C, et al. Non-alcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103-9.
39. George DK, Goldwurm S, MacDonald GA, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114: 311-8.
40. Cauza E, Peck-Radosavljevic M, Ulrich-Pur H, et al. Mutations of the HFE gene in patients with hepatocellular carcinoma. Am J Gastroenterol 2003; 98: 442-7.
41. Skowron F, Berard F, Grezard P, Wolf E, Morel Y, Perrot H. Role of the hemochromatosis gene in porphyria cutanea tarda. Prospective study of 56 cases. Ann Dermatol Venereol 2001; 128: 600-4.
42. Rasmussen ML, Folasom AR, Catellier DJ, et al. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2001; 154: 739-46.
43. Hetet G, Elbaz A, Gariepy J, et al. Association studies between hemochromatosis gene mutations and the risk of cardiovascular diseases. Eur J Clin Invest 2001; 31: 382-8.
44. Mahon NG, Coonar AS, Jeffery S, et al. Hemochromatosis gene mutations in idiopathic dilated cardiomyopathy. Heart 2000; 84: 541-7.
45. Butterworth JR, Cooper BT, Rosenberg WM, et al. The role of hemochromatosis susceptibility gene mutations in protecting against iron deficiency in celiac disease. Gastroenterology 2002; 123: 444-9.
46. Shaheen NJ, Silverman LM, Keku T, et al. Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. J Natl Cancer Inst 2003; 95: 154-9.
47. Li J, Zhu Y, Singal DP. HFE mutations in patients with rheumatoid arthritis. J Rheumatol 2000; 27: 2074-7.
48. Lonardo A, Neri P, Mascia MT, Pietrangelo A. Hereditary hemochromatosis masquerading as rheumatoid arthritis. Ann Ital Med Int 2001; 16: 46-9.
49. Hannuksela J, Savolainen ER, Koistinen P, et al. Prevalence of HFE genotypes, C282Y and H63D, in patients with hematologic disorders. Haematologica 2002; 87: 131-5.
50. Dorak MT, Burnett AK, Worwood M. Hemochromatosis gene in leukemia and lymphoma. Leuk Lymphoma 2002; 43: 467-77.
51. Moalem S, Percy ME, Andrews DF, et al. Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am J Med Genet 2000; 93: 58-66.
52. Sampietro M, Caputo L, Casatta A, et al. The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease. Neurobiol Aging 2001; 22: 563-8.
53. Martinez di Montemuros F, Tavazzi D, Salsano E, et al. High frequency of the H63D mutation of the hemochromatosis gene (HFE) in malignant gliomas. Neurology 2001; 57: 1342.